Figure 2.
Univariate and multivariate Cox-proportional hazards model for PFS of patients receiving CDK4/6i.
CDK4/6i, cyclin-dependent kinase 4/6 inhibitor; PFS, progression-free survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.